Poorer nations face vaccine wait
Hailed this week as a pandemic game-changer, the new Covid-19 vaccine offered countries that had pre-ordered doses a potential escape from a cycle of lockdowns and new waves of sickness and death.
But while richer nations plan their vaccination programmes through the end of 2021, experts warn that poorer and developing countries face hurdles that could deny billions the first proven protection against the coronavirus.
https://sign.moveon.org/petitions/all-among-us-hack-always-imposter-among-us-mod-unlock-skins-pets-hats https://sign.moveon.org/petitions/working-among-us-hack-always-imposter-2020-among-us-hack-mod-menu https://sign.moveon.org/petitions/always-imposter-among-us-cheat-unlock-all-characters-skins-pets-hats https://sign.moveon.org/petitions/innersloth-among-us-mod-always-imposter-among-us-unlock-all-skins-pets-hats-characters
Vaccine developers Pfizer and BioNTech plan to roll out the first doses within weeks, once they receive emergency use permissions from drug agencies. They expect to have 1.3 billion doses ready next year.
The results of phase 3 clinical trials showed their mRNA vaccine was 90 percent effective in preventing Covid-19 symptoms and did not produce adverse side effects among thousands of volunteers.
At the cost of $40 per treatment, which consists of two separate shots, richer nations have rushed to order tens of millions of doses. But it is less clear what poorer nations can expect.